We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Lin Chang

Lin Chang MD

Vice-Chief, Vatche and Tamar Manoukian Division of Digestive Diseases; Program Director, UCLA GI Fellowship Program; Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience, David Geffen School of Medicine at UCLA, Los Angeles, California

Lin Chang, MD, is a Professor of Medicine and Vice-Chief of the Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine at the David Geffen School of Medicine at UCLA. At UCLA, she serves as the Co-Director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience, Program Director of the Gastroenterology Fellowship Program, and oversees the GI Integrative Health Program. Dr. Chang’s clinical expertise is in disorders of gut-brain interaction (also known as functional gastrointestinal disorders). Her research focuses on brain-gut interactions underlying irritable bowel syndrome (IBS), specifically, the pathophysiology of IBS related to stress, early life adversity, sex differences, genetic and epigenetic factors, and gut microbiome and the treatment of IBS. She is a fellow of the American Gastroenterological Association (AGA) and American College of Gastroenterology (ACG). She is currently the Clinical Research Councilor of the AGA Governing Board. She previously served as President of the American Neurogastroenterology and Motility Society (ANMS) and is a member of the Rome Foundation Board of Directors.

Disclosures

Dr. Chang reports the following disclosures:
Scientific advisory boards: Ironwood, Arena, Alfasigma
Consultant: Allergan, Shire Takeda, IM HealthSciences
Speaker: Salix
Rome Foundation Board of Directors member
Stock options: Modify Health